José Ángel Santiago-Cruz

Dr. José Ángel Santiago-Cruz

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MTMaritza Velásquez Torres
Maritza Velásquez Torres
JTJosé G. Trujillo-Ferrara
José G. Trujillo-Ferrara
MVMarycarmen Godínez Victoria
Marycarmen Godínez Victoria
RJRosa Adriana Jarillo-Luna
Rosa Adriana Jarillo-Luna
VTVíctor Tsutsumi
Víctor Tsutsumi
JPJudith Pacheco-Yépez
Judith Pacheco-Yépez
Amoebiasis is produced by the parasite Entamoeba histolytica; this disease affects millions of people throughout the world who may suffer from amoebic colitis or amoebic liver abscess. Metronidazole is used to treat this protozoan, but it causes important adverse effects that limit its use. Studies have shown that riluzole has demonstrated activity against some parasites. Thus, the present study aimed, for the first time, to demonstrate the in vitro and in silico anti-amoebic activity of riluzole. In vitro, the results of Entamoeba histolytica trophozoites treated with IC50 (319.5 μM) of riluzole for 5 h showed (i) a decrease of 48.1% in amoeba viability, (ii) ultrastructural changes such as a loss of plasma membrane continuity and alterations in the nuclei followed by lysis, (iii) apoptosis-like cell death, (iv) the triggering of the production of reactive oxygen species and nitric oxide, and (v) the downregulation of amoebic antioxidant enzyme gene expression. Interestingly, docking studies have indicated that riluzole presented a higher affinity than metronidazole for the antioxidant enzymes thioredoxin, thioredoxin reductase, rubrerythrin, and peroxiredoxin of Entamoeba histolytica, which are considered as possible candidates of molecular targets. Our results suggest that riluzole could be an alternative treatment against Entamoeba histolytica. Future studies should be conducted to analyze the in vivo riluzole anti-amoebic effect on the resolution of amebic liver abscess in a susceptible model, as this will contribute to developing new therapeutic agents with anti-amoebic activity.

29 August 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
APAngélica Pérez-Juárez
Angélica Pérez-Juárez
JAJ Leopoldo Aguilar-Faisal
J Leopoldo Aguilar-Faisal
Araceli Posadas-MondragónAraceli Posadas-Mondragón
Araceli Posadas-Mondragón
JSJosé Ángel Santiago-Cruz
José Ángel Santiago-Cruz
BCBarrientos Cornelio
Barrientos Cornelio
JMJose A. Morales-González
Jose A. Morales-González
Spirulina (formerly Arthrospira) maxima (SP) is a cyanobacterium reported to have great nutritional and pharmacological potential. The objective of this study was to evaluate the protective properties of SP against ethanol-induced toxicity. Male Wistar rats were used in the study and subjected to a 70% partial hepatectomy (PH); they were then divided into five groups. During the experiment, animals in two groups drank an aqueous solution of ethanol (EtOH) (40%, v/v). Additionally, they were administered an SP extract daily at a dose of 200 mg/kg body weight intragastrically. To explore possible mechanisms of action, we examined antioxidant defense enzymes, as well as serum biochemical parameters and histopathological changes in the liver. SP administration normalized elevated glutathione reductase (GR), glutathione (GSH), and superoxide dismutase (SOD) levels, in addition to increased catalase (CAT) and glutathione peroxidase (GPX) enzymes. Alterations in biochemical parameters were observed in the groups with PH treated with EtOH associated with a reduction in cholesterol and albumin levels, while glucose and triglyceride levels increased. The histological study supported the protective activity of SP, reducing apoptosis, necrosis, and congestion in the liver. Our findings demonstrated a protective effect of SP against EtOH that is related to less inflammation, a lesser antioxidant effect, and less free radical scavenging activity.

8 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Araceli Posadas-MondragónAraceli Posadas-Mondragón
Araceli Posadas-Mondragón
JSJosé Ángel Santiago-Cruz
José Ángel Santiago-Cruz
APANGELICA PEREZ-JUAREZ
ANGELICA PEREZ-JUAREZ
NHNorma Estela Herrera-González
Norma Estela Herrera-González
NSNA Sara Sosa-Delgado
NA Sara Sosa-Delgado
JAJ Leopoldo Aguilar-Faisal
J Leopoldo Aguilar-Faisal
Dengue (DENV) and Chikungunya (CHIKV) viruses can be transmitted simultaneously by Aedes mosquitoes, and there may be co-infections in humans. However, how the adaptive immune response is modified in the host has yet to be known entirely. In this study, we analyzed the cross-reactivity and neutralizing activity of IgG antibodies against DENV and CHIKV in sera of patients from the Mexican Institute of Social Security in Veracruz, Mexico, collected in 2013 and 2015 and using IgG antibodies of BALB/c mice inoculated with DENV and/or CHIKV. Mice first inoculated with DENV and then with CHIKV produced IgG antibodies that neutralized both viruses. Mice were inoculated with CHIKV, and then with DENV; they had IgG antibodies with more significant anti-CHIKV IgG antibody neutralizing activity. However, the inoculation only with CHIKV resulted in better neutralization of DENV2. In sera obtained from patients in 2013, significant cross-reactivity and low anti-CHIKV IgG antibody neutralizing activity were observed. In CHIKV-positive 2015 sera, the anti-DENV IgG antibody neutralizing activity was high. These results suggest that CHIKV stimulates DENV2-induced memory responses and vice versa. Furthermore, cross-reactivity between the two viruses generated neutralizing antibodies, but exchanging CHIKV for DENV2 generated a better anti-CHIKV neutralizing response.

5 December 2025 in Viruses
Verified
Journal Article
Open access
PDF file
JSJosé Ángel Santiago-Cruz
José Ángel Santiago-Cruz
Araceli Posadas-MondragónAraceli Posadas-Mondragón
Araceli Posadas-Mondragón
JAJosé Leopoldo Aguilar-Faisal
José Leopoldo Aguilar-Faisal
COCesar Ismael Ortiz-García
Cesar Ismael Ortiz-García
DMDanai Montalvan-Sorrosa
Danai Montalvan-Sorrosa
APANGELICA PEREZ-JUAREZ
ANGELICA PEREZ-JUAREZ
Chikungunya fever (CHIKV) has reemerged as a serious global health problem worldwide. Currently, no antiviral drugs are available for the prevention or treatment of CHIKV infection. Therefore, this study aimed to analyze the anti-CHIKV potential of the alga Spirulina maxima. Extracts were obtained by maceration using solvents of different polarities (hexane, dichloromethane, and methanol). The cytotoxic activity of the extracts was evaluated using the MTT assay, which demonstrated that none of the extracts had a cytotoxic effect on VERO and BJ cell lines. The anti-CHIKV effect was evaluated using a plate assay with VERO, HepG2, and BJ cell lines. The results showed that the methanol extract had the best anti-CHIKV effect, completely inhibiting viral replication at a concentration of 15 µg/mL in all three cell lines. Furthermore, the addition time assay suggested that the mechanism of action is related to the inhibition of some processes at the beginning of the infection, such as the entry or early replication of the virus. In conclusion, SP contains molecules that could provide a basis for future research on the development of new drug therapies against CHIKV.

17 December 2024 in Viruses
Verified
Journal Article
Open access
PDF file
JSJosé Ángel Santiago-Cruz
José Ángel Santiago-Cruz
Araceli Posadas-MondragónAraceli Posadas-Mondragón
Araceli Posadas-Mondragón
APANGELICA PEREZ-JUAREZ
ANGELICA PEREZ-JUAREZ
NHNorma Estela Herrera-Gonzalez
Norma Estela Herrera-Gonzalez
JCJosé Miguel Chin-Chan
José Miguel Chin-Chan
JAJ Leopoldo Aguilar-Faisal
J Leopoldo Aguilar-Faisal
Chikungunya virus (CHIKV) is classified as a pathogen with the potential to cause a pandemic. This situation becomes more alarming since no approved drug exists to combat the virus. The present research aims to demonstrate the anti-CHIKV activity of molecules present in the latex of Euphorbia grandicornis. Therefore, a biodirected assay was carried out to find the molecules with anti-CHIKV activity. Extractions with hexane, dichloromethane, and methanol and subsequent purification by column chromatography were carried out to later evaluate cytotoxic activity by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and antiviral activity by plaque assay. Our findings show that unlike the others, methanolic extract has a low cytotoxic effect and a good anti-CHIKV effect (EC50 = 26.41 µg/mL), which increases when obtaining the purified active fraction (pAFeg1) (EC50 = 0.4835 µg/mL). Time-of-addition suggests that the possible mechanism of action of pAFeg1 could be inhibiting any of the non-structural proteins of CHIKV. In addition, both the cytotoxic and anti-CHIKV activity of pAFeg1 demonstrate selectivity since it killed cancer cells and could not inhibit DENV2.